What is the PDA (Patent Ductus Arteriosus) vessel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is the PDA Vessel?

The PDA (Patent Ductus Arteriosus) is a vascular connection between the aorta and the pulmonary artery that normally exists during fetal life but persists beyond the normal age of spontaneous closure after birth. 1

Anatomical Definition

  • The ductus arteriosus connects the descending aorta (just distal to the left subclavian artery) to the pulmonary artery 1
  • This vessel is essential for normal fetal development, allowing blood to bypass the non-functioning fetal lungs 2, 3
  • Normal closure occurs within the first 3 days after birth in term infants 4
  • When this vessel remains open beyond the normal closure period, it is termed "patent" ductus arteriosus 1

Epidemiology

  • PDA occurs in approximately 0.3% to 0.8% of term infants 1, 5
  • It is twice as common in females compared to males 1, 5
  • The incidence is inversely related to gestational age—up to 80% of infants born at 25-28 weeks gestation have delayed closure 4
  • PDA accounts for 5-10% of all congenital heart disease in term infants 6

Physiological Mechanism of Closure

  • Postnatal closure is triggered by rising oxygen tension and withdrawal of vasodilatory mediators (prostaglandins, nitric oxide, adenosine) 2
  • Vasoconstrictors including endothelin-1, catecholamines, and contractile prostanoids promote closure 2
  • The process involves complex cell-matrix interactions between smooth muscle cells, endothelial cells, and extracellular matrix components 3
  • In preterm infants, the normal physiologic mechanisms contributing to closure are altered due to immaturity 6

Hemodynamic Consequences

  • The clinical manifestations depend on the size of the vessel and the relative systemic and pulmonary vascular resistances 1, 5
  • PDA initially results in left-to-right shunting and left ventricular volume overload 1
  • As pulmonary vascular resistance decreases (especially in extremely premature infants), left-to-right shunting increases, leading to pulmonary overcirculation and systemic hypoperfusion 2, 4
  • Large untreated PDAs can cause congestive heart failure and pulmonary hypertension 1, 5
  • In severe cases with elevated pulmonary vascular resistance, shunt reversal occurs, resulting in Eisenmenger physiology with right-to-left shunting 1, 7

Classification by Size and Hemodynamic Significance

  • Trivial/silent PDA: Hemodynamically insignificant, no audible murmur 1, 8
  • Small/audible PDA: Likely hemodynamically insignificant, continuous murmur present 1, 8
  • Moderate to large PDA: Hemodynamically significant with left heart volume overload 1

Associated Complications

  • Potential complications of hemodynamically significant PDA include prolonged ventilation, bronchopulmonary dysplasia, necrotizing enterocolitis, intraventricular hemorrhage, and death 2
  • There is a risk of infective endarteritis, though this appears relatively low 1, 7
  • Rare complications include aneurysm formation of the duct, which may compress the left main coronary artery 1
  • Long-term morbidities include chronic lung disease, retinopathy of prematurity, and neurodevelopmental delay 4

Clinical Presentation Patterns in Adults

  • Small duct with no left ventricular volume overload and normal pulmonary artery pressure (generally asymptomatic) 1
  • Moderate PDA with predominant left ventricular volume overload may present with left heart failure 1, 5
  • Moderate PDA with predominant pulmonary hypertension presents with pressure-overloaded right ventricle and potential right heart failure 1
  • Large PDA with Eisenmenger physiology demonstrates differential hypoxemia and differential cyanosis (lower extremities cyanotic, sometimes left arm too) 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Understanding the Pathophysiology, Implications, and Treatment Options of Patent Ductus Arteriosus in the Neonatal Population.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2019

Guideline

Patent Ductus Arteriosus Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Patent ductus arteriosus: an overview.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2007

Guideline

Arrhythmia Management in Eisenmenger Physiology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hemodynamically and Clinically Stable Patent Ductus Arteriosus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.